Ultimovacs ASA: Mandatory notification of trade by primary insider
Zelluna ASA (ZLNA) · publisert 2. januar 2024 kl. 19:25 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Carlos de Sousa | CEO | acquisition | 1 500 | 119,75 NOK | 2. januar 2024 | NO0010851603 | XOSL | llm |
| Elliot DE SOUSA nærstående | – | acquisition | 1 000 | 120 NOK | 2. januar 2024 | NO0010851603 | XOSL | llm |
Vedlegg
- 20240102 - Ultimovacs Notification of trade - CDS1 - KRT 1500.pdf (tekst hentet ut)
- 20240102 - Ultimovacs Notification of trade - CDS2 - KRT 1500.pdf (tekst hentet ut)
Meldingstekst
Oslo, 2 January 2024: Carlos de Sousa, Chief Executive Officer and primary
insider in Ultimovacs ASA, has today bought 1,500 shares in the company at an
average price of NOK 119.75 per share. In addition, a closely related party of
Carlos de Sousa, Chief Executive Officer and primary insider in Ultimovacs ASA,
has today bought 1,000 shares in the company at an average price of NOK 120.00
per share. Following these transactions, Carlos de Sousa and closely related
parties hold 25,556 shares and 425,535 share options in Ultimovacs ASA.
This information is subject to the disclosure requirements pursuant to the
Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities
Trading Act.